cell-based diagnostics
Investigators See Future for NanoVelcro Cell Technology in Diagnosis of Pregnancy Complications
Premium
Researchers demonstrated that detection of single and clustered circulating trophoblasts could reliably differentiate placenta accreta from normal controls and other disorders, even early in gestation.
The Bay Area startup is offering a no-touch method to separate cell populations for downstream analysis in genomics and synthetic biology applications.
Biolidics, A*STAR Genome Institute of Singapore to Develop Liquid Biopsy Breast Cancer Test
The company will work with the Genome Institute of Singapore to create a test for breast cancer recurrence prediction using its circulating tumor cell platform.
Clearbridge Signs China Distribution, Test Development Deal with Agen Lab
The company will supply the Chinese laboratory with its ClearCell FX1 system and help train and assist its new partner in developing cancer tests.
Singapore's Clearbridge Biomedics Secures S$6.6M in Funding Ahead of Planned IPO
The financing will support business expansion, continued technology development, and expenses related to a planned listing at the end of the year.